Related Articles
Synthesis and positron emission tomography evaluation of 18F-Glu-Urea-Lys, a prostate-specific membrane antigen-based imaging agent for prostate cancer Corrigendum in /10.3892/ol.2015.4039
In vivo targeted killing of prostate tumor cells by a synthetic amoebapore helix 3 peptide modified with two γ-linked glutamate residues at the COOH terminus
Targeting foreign major histocompatibility complex molecules to tumors by tumor cell specific single chain antibody (scFv)
Expression, purification and identification of an immunogenic fragment in the ectodomain of prostate‑specific membrane antigen
Development of a 124I-labeled version of the anti-PSMA monoclonal antibody capromab for immunoPET staging of prostate cancer: Aspects of labeling chemistry and biodistribution